Skip to main content
. 2017 May 3;8(29):47216–47229. doi: 10.18632/oncotarget.17590

Figure 2. Patient outcome stratified by SULF1 and SULF2 transcript levels based on GSE31684.

Figure 2

The expression level of SULF1 significantly predicts worse patient outcome (left, P = 0.0345). While SULF2 expression status is not predictive for patient survival (right, P = 0.1332).